Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1

Han, Jing; Chen, Xin; Xu, Jiawei; Chu, Laili; Li, Rongqing; Sun, Na; Jiang, Zhen; Liu, Hongyang; Ge, Xing; Zheng, Junnian; Yang, Jing; Ikezoe, Takayuki

doi:10.7150/ijms.61969



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2021; 18(15):3437-3451. doi:10.7150/ijms.61969 This issue Cite

Research Paper

Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1

Jing Han^1,2*, Xin Chen^1,2*, Jiawei Xu^1,2,4*, Laili Chu^3*, Rongqing Li^1,2, Na Sun^1,2, Zhen Jiang^1,2,4, Hongyang Liu^1,2,4, Xing Ge^1,2, Junnian Zheng^3,5✉, Jing Yang^1,2✉, Takayuki Ikezoe⁶

1. Jiangsu Province Key Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
2. Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
3. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
4. National Experimental Demonstration Center for Basic Medicine Education, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
5. Department of Oncology, the first affiliated hospital, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
6. The Department of Hematology, Fukushima Medical University, Fukushima, Japan.
*These authors have contributed equally to this work.

Citation:

Han J, Chen X, Xu J, Chu L, Li R, Sun N, Jiang Z, Liu H, Ge X, Zheng J, Yang J, Ikezoe T. Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1. Int J Med Sci 2021; 18(15):3437-3451. doi:10.7150/ijms.61969. https://www.medsci.org/v18p3437.htm

Other styles

Abstract

Aurora-A has attracted a great deal of interest as a potential therapeutic target for patients with CRC. However, the outcomes of inhibitors targeting Aurora-A are not as favorable as expected, and the basis behind the ineffectiveness remains unknown. Here, we found that signal transducer and activator of transcription 1 (STAT1) was highly expressed in colorectal cancer (CRC) xenograft mouse models that were resistant to alisertib, an Aurora-A inhibitor. Unexpectedly, we found that alisertib disrupted Aurora-A binding with ubiquitin-like with plant homeodomain and ring finger domain 1 (UHRF1), leading to UHRF1 mediated ubiquitination and degradation of DNA methyltransferase 1 (DNMT1), which in turn resulted in demethylation of CpG islands of STAT1 promoter and STAT1 overexpression. Simultaneous silencing Aurora-A and UHRF1 prevented STAT1 overexpression and effectively inhibited CRC growth. Hence, concomitant targeting Aurora-A and UHRF1 can be a promising therapeutic strategy for CRC.

Keywords: Aurora-A, UHRF1, STAT1, colorectal cancer cell

Citation styles

APA

Han, J., Chen, X., Xu, J., Chu, L., Li, R., Sun, N., Jiang, Z., Liu, H., Ge, X., Zheng, J., Yang, J., Ikezoe, T. (2021). Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1. International Journal of Medical Sciences, 18(15), 3437-3451. https://doi.org/10.7150/ijms.61969.

ACS

Han, J.; Chen, X.; Xu, J.; Chu, L.; Li, R.; Sun, N.; Jiang, Z.; Liu, H.; Ge, X.; Zheng, J.; Yang, J.; Ikezoe, T. Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1. Int. J. Med. Sci. 2021, 18 (15), 3437-3451. DOI: 10.7150/ijms.61969.

NLM

CSE

Han J, Chen X, Xu J, Chu L, Li R, Sun N, Jiang Z, Liu H, Ge X, Zheng J, Yang J, Ikezoe T. 2021. Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1. Int J Med Sci. 18(15):3437-3451.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.